跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
达唯珂 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Tazemetostat Hydrobromide Tablets
Approved
化学药品
Tazemetostat Hydrobromide Tablets
Epizyme, Inc.
🇨🇳 National Medical Products Administration
Approval Date
Mar 18, 2025
Approval ID
8jXhzQrOe6p
Company
Epizyme, Inc.
Type
化学药品
Approval Details
Approval Id
8jXhzQrOe6p
Approval Number
国药准字HJ20250031
Generic Name
氢溴酸他泽司他片
Generic Name En
Tazemetostat Hydrobromide Tablets
Trade Name
达唯珂
Drug Type
化学药品
Dosage Form
片剂
Strength
200mg(按C₃₄H₄₄N₄O₄计)
Reg Date
2025-03-18
Expired Date
2030-03-17
Company Name
Epizyme, Inc.
Production Company Name
PATHEON PHARMACEUTICALS INC.
Company Detail Path
/organization/epizyme-inc
Production Company Detail Path
/organization/patheon-pharmaceuticals-inc
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Mar 18, 2025
Approval ID
8jXhzQrOe6p
Type
化学药品
Back to NMPA Approvals